The second issue with having just baseline measurements for this group is whether, as diet drink consumers, they are more likely to make significant changes to their diet and behavior over the course of a decade.
The goal was to see how this population would react to the introduction of abuse-resistant OxyContin after establishing a baseline of abuse with the same group for the original version.
In BLOOM 1 there was an increase in the total number of satisfying sexual events of 3.87 from baseline (an increase of 83 percent) in the LibiGel group and in the placebo group there was an increase of 3.52 satisfying sexual events from baseline (an increase of 65 percent) for a p value of 0.698.